U.S. Markets open in 4 hrs 4 mins
  • S&P Futures

    4,311.75
    -6.00 (-0.14%)
     
  • Dow Futures

    33,948.00
    -95.00 (-0.28%)
     
  • Nasdaq Futures

    14,035.25
    +48.50 (+0.35%)
     
  • Russell 2000 Futures

    1,910.60
    -17.70 (-0.92%)
     
  • Crude Oil

    87.16
    +0.55 (+0.64%)
     
  • Gold

    1,789.90
    -3.20 (-0.18%)
     
  • Silver

    22.53
    -0.15 (-0.64%)
     
  • EUR/USD

    1.1136
    -0.0011 (-0.1002%)
     
  • 10-Yr Bond

    1.8070
    0.0000 (0.00%)
     
  • Vix

    30.82
    -1.14 (-3.57%)
     
  • GBP/USD

    1.3380
    -0.0001 (-0.0080%)
     
  • USD/JPY

    115.6400
    +0.3380 (+0.2931%)
     
  • BTC-USD

    36,590.27
    -3.37 (-0.01%)
     
  • CMC Crypto 200

    829.27
    +9.77 (+1.19%)
     
  • FTSE 100

    7,473.51
    -80.80 (-1.07%)
     
  • Nikkei 225

    26,717.34
    +547.04 (+2.09%)
     

Here's Why Biotech Stocks Adaptimmune Therapeutics, Agenus, and Ocugen All Crashed in November

·3 min read
Here's Why Biotech Stocks Adaptimmune Therapeutics, Agenus, and Ocugen All Crashed in November
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • AGEN
  • ADAP
  • OCGN

A mix of marketwide headwinds and company-specific events weighed on these three biotech stocks in November.